IQVIA Holdings Inc.

Laboratory Corporation of America Holdings

- Outsourcing in the biotech and pharma industry continues unabated, projected to reach almost 50% penetration next year.
- This is boosting contract research organisations (CRO) like $IQV $LH
- Interestingly consolidation has been a big feature of the industry, and this expert [call](https://stream.alpha-sense.com/?docid=EC-081822-115467&utm_source=alphasense%20platform&utm_medium=document%20share&utm_content=EC-081822-115467&utm_campaign=1663068542087) (professional investors can [sign up](https://stream.alpha-sense.com/enterprise-signup/?utm_source=sponsored&utm_medium=partner&utm_campaign=RF_STM_Snippet-Finance&utm_content=) for free two weeks to access) from Stream suggests more is to come.
- [Source](https://resultsig.com/wp-content/uploads/2022/02/CRO-sector-MA-drivers-and-market-trends-Q1-2022-Results-Healthcare.pdf).


![Image upload](https://cdn.commonstock.com/09e7ad72eec17a0b29c33614b5fb7bba150e1ca9836f50c8726ea8665fc078ab-2308x1230.png)

A really interesting insight about biotech and pharma. I guess CROs are designed to reduce costs for companies developing new medicines and drugs in niche markets this appears to be the commercial way forward for them and will definitely reduce the need for in-house trials or research.

Thanks for sharing Snippet

Joey Hirendernath

https://resultsig.com/wp-content/uploads/2022/02/CRO-sector-MA-drivers-and-market-trends-Q1-2022-Results-Healthcare.pdf

https://stream.alpha-sense.com/?docid=EC-081822-115467&utm_source=alphasense%20platform&utm_medium=document%20share&utm_content=EC-081822-115467&utm_campaign=1663068542087

AlphaSense

https://stream.alpha-sense.com/enterprise-signup/?utm_source=sponsored&utm_medium=partner&utm_campaign=RF_STM_Snippet-Finance&utm_content=

CRO Industry

This member is verified by the Commonstock team based on their contributions to the Commonstock community. 